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Introduction: The use of PROs for assessing the outcomes of emergency hospital admis-
sions requires a means of estimating patients’ pre-admission health status. A possible alter-
native to asking patients to recall how their health was before the incident causing admission
is to use estimates derived from matched samples from population surveys. Our aims were to
explore the impact of different methods of matching and to compare the results with
estimates based on retrospective reporting.
Methods: First, elective hip arthroplasty patients were matched to respondents to the
General Practice Patient Survey using age, sex, socio-economic status and number of
comorbidities. The impact of restricting matching for locality and specific co-morbidities
was explored. Second, the best matching method was applied to emergency admissions for
laparotomy and for percutaneous coronary intervention (PCI) after acute myocardial infarc-
tion. Data were stratified by patient characteristics. Differences in mean EQ-5D scores
between the patients and matched population respondents were tested using t tests.
Results: Modifying the most basic form of matching by also taking locality and the specific
comorbid conditions into account made no significant difference to the mean EQ-5D score
for hip arthroplasty patients. Even using the most detailed matching possible, patients’ mean
EQ-5D score was significantly different to that of the general population for all three cohorts.
The difference was greatest for elective hip arthroplasty (0.22 v 0.64), less so for emergency
laparotomy (0.56 v 0.72) and least for PCI (0.79 v 0.71). This reflects hip arthroplasty
patients having a long-standing condition characterised by pain and limited mobility, whereas
the other two cohorts may have enjoyed reasonable health until an unexpected acute episode
led to their emergency admission.
Conclusion: Routine PRO data acquired from population surveys cannot be used as an
accurate alternative to retrospectively reported PROMs by patients during their emergency
admission episode.
Keywords: patient-reported outcome measures, health status, health-related quality of life,
self- report, retrospective, hospital admission, general population patient survey
Introduction
Patient-Reported Outcomes (PROs) have the potential to enhance the clinical
management of patients and to assess the quality of providers’ performance.1,2 To
date, use of PROs in assessing the outcome of hospital admissions has been largely
restricted in elective surgery where before and after measurements of patients’
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symptoms, functional status and health-related quality of
life can be compared. The challenge for use in emergency
admissions is how to measure a patient’s health status
prior to an unexpected incident that caused an emergency
admission.
It is not feasible to collect a pre-admission PRO but the
use of retrospective or recalled assessment by patients has
been established as a reliable alternative method. Studies of
elective admissions have shown that retrospective PRO
scores have high agreement with scores collected from
patients before admission. Strong associations were found
between retrospective and contemporary PROs in 21 out of
30 comparisons (correlation coefficients over 0.68) and 20 of
24 showed strong agreement (intraclass correlations over
0.75). A further study demonstrated the feasibility of using
retrospective PROs in the NHS in England. That study found
strong agreement between retrospective and contemporary
disease-specific PROs and EQ-5D, with intra-class correla-
tion coefficients of 0.8 for the disease-specific PROs (Oxford
Hip Score andOxfordKnee Score), and 0.6 for the EQ-5D.3,4
An alternative approach that has been suggested is to
derive expected PRO scores from respondents to general
population surveys. Nine of the ten studies that have com-
pared retrospective and population PRO scores have been
conducted with trauma patients. Seven studies reported that,
on average, patients recalled their health status as being
better than that derived from age-sex-matched population
samples5–11 while three reported no difference.12–14 These
findings probably reflect that many trauma cases are from
road traffic accidents among relatively healthy young
adults. The only study that has considered non-trauma
patients (intensive care unit patients with acute lung injury)
reported their recalled health status was, on average, worse
than that derived from population norms.15
Although the use of population norms has cost advan-
tages, including less patient and staff burden of data col-
lection, there is uncertainty as to whether it would provide
a relevant and accurate assessment of pre-admission health
status for groups of patients admitted to hospitals. It may
be that with more extensive matching techniques, mean-
ingful estimations of baseline health are possible for cer-
tain groups of patients, conditions and diseases. It is
plausible that the baseline health status of patients
admitted with sudden onset unexpected emergencies may
have greater similarity with those in the population than is
true for trauma admissions.
In this study, we make use of data from the English
General Practice Patient Survey (GPPS), which included
the EQ-5D instrument between 2011 and 2017 along with
basic demographic information and self-reported co-
morbidities.16 This rich population-based dataset offers the
possibility of matching for several patient characteristics.
Our first aim was to explore the benefits of matching
by comparing retrospective self-reported health status
(mean EQ-5D scores) of hip arthroplasty patients with
that of the general population of England. The second
aim was to test the benefits of different matching techni-
ques. The third aim was to test the impact of the optimum
matching method by comparing mean differences between
population EQ-5D scores and those reported retrospec-
tively by patients admitted for elective hip arthroplasty,
emergency laparotomy and acute myocardial infarction.
Methods
Patients who participated in one of three cohort studies
(receiving either an elective hip arthroplasty, emergency lapar-
otomy for gastro-intestinal conditions (excluding appendicitis)
or emergency percutaneous coronary intervention (PCI) after
a myocardial infarction) were matched to GPPS respondents
using several patient characteristics. Each patient was matched
to as many GPPS respondents as fitted the matching criteria.
The mean GPPS EQ-5D score for all those matched to
a patient was used to compare with the patient’s retrospec-
tively reported EQ-5D.
Population Sample from GPPS
Data from the 2011–2012 GPPS (held at the University of
Exeter) included the EQ-5D-3L, the same version as that
used for the patient cohort. Questionnaires were sent in two
waves, July 2011 and January 2012, to approximately 1.40
and 1.36 million patients, respectively. Non-responders were
mailed a reminder in each of the two months following the
initial questionnaire. Of the 2.76 million patients surveyed,
38% responded resulting in a sample of 1,037,946. Patients
sent the GPPS comprise a stratified random sample of all
adults registered with a general practice. Full details of the
survey and its development are published elsewhere.17
Alongside patient experience items, patients were asked
to report any long-standing health condition from a list of
twelve common conditions: angina or long-term heart pro-
blem, arthritis or long-term joint problem, asthma or long-
term chest problem, cancer in the last 5 years, deafness or
severe hearing impairment, diabetes, epilepsy, high blood
pressure, kidney or liver disease, long-term back problem,
long-term mental health problem, long-term neurological
problem and “another” long-term condition.18 They also
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reported age (18–24, 25–34, 35–44, 45–54, 55–64, 65–74,
75–84, and 85+ years) and sex. Further, their postcode of
residence was used to assign a measure of socio-economic
status, the Index of Multiple Deprivation (IMD).
EQ-5D
The EQ-5D-3L is a generic PRO on a three-level ordinal scale
(no problems, moderate problems and severe problems) for
each of its five dimensions (mobility, self-care, usual activities,
pain/discomfort and anxiety/depression).19 UK tariffs of utility
were used to obtain an index score which ranges from −0.59
(the worst possible health state) to 1 (indicates best possible
health state). The value of 0 is equal to death and negative
values represent health states worse than death.20
Patient Cohorts: Hip Arthroplasty,
Emergency Laparotomy and PCI
EQ-5D from patients (n= 244) who had undergone hip arthro-
plasty (primary operation or revision surgery) in one of four
NHS hospitals reported their pre-operative health status retro-
spectively in the immediate post-operative period prior to their
discharge from hospital (Health Research Authority ethics
approval was obtained from North East - Newcastle & North
Tyneside 2 Research Ethics Committee (REC Ref: 16/NE/
0081)).4 The mean EQ-5D score of the cohort was similar to
that for all patients’ in a national audit in England. Information
on comorbidity had previously been collected in a pre-
operative questionnaire and covered: heart disease (for exam-
ple, angina, heart attack or heart failure), high blood pressure,
problems caused by a stroke, leg pain due to poor circulation,
lung disease, diabetes, kidney disease, liver disease, cancer
(within in the last 5 years), diseases of the nervous system
(for example, Parkinson’s disease or multiple sclerosis),
depression.
Emergency laparotomy patients (n= 261) and PCI patients
(n= 396) were recruited from 11 and five NHS hospitals,
respectively. Patients completed a retrospective questionnaire
in the immediate period prior to their discharge from hospital
following their emergency admission. The study received
ethics approval from South East Coast - Brighton & Sussex
Research Ethics Committee (REC reference: 16/LO/2053).21
The questionnaire included the same question about comor-
bidity as used for the hip arthroplasty study.
Matching Patients to Population Sample
Patients were matched to GPPS population on sex, age,
socioeconomic status and number of co-morbidities. The
sample sizes were large enough, relative to the number of
matching characteristics, to permit exact one-to-manymatch-
ing. Age was categorised: 18–24, 25–34, 35–44, 45–54,
55–64, 65–74, 75–84, and 85+ years. Socioeconomic status
(SES) was derived from the Index of Multiple Deprivation
(IMD) of a patient’s local area (LSOAs) based on postcode,
which was then grouped into quintiles based on the national
ranking of areas by IMD to match the GPPS variable.22 Co-
morbid conditions reported in the patient cohorts were
mapped to the categories collected in the GPPS (Table 1).
Patients were matched to GPPS using personal char-
acteristics available in both datasets. One-to-many match-
ing was conducted, with one patient matched to as many
GPPS respondents as fitted the matching criteria. The
mean EQ-5D score of all GPPS respondents matched to
a patient was used in the comparison between patients’
reported EQ-5D and GPPS EQ-5D. Mean EQ-5D scores
for patients and for the population were compared.
First, exploratory matching was conducted with hip
arthroplasty patients to determine whether the specific
way of matching would change the differences between
population and patients’ mean EQ-5D scores. Matching
for age, sex, SES and number of comorbidities was com-
pared with (i) restricting matching to GPPS respondents
living in the same local authority and (ii) matching
patients on the basis of specific combinations of co-
morbidities. Data were stratified by patient characteristics
and t tests were carried out to compare differences
between patients’ EQ-5D means and population EQ-5D
means by patient characteristics. As is customary, a p
value of less than 0.05 was deemed statistically significant.
Second, influenced by the findings of the first phase,
analysis of the emergency laparotomy and PCI patients
was conducted. Similarly, data were stratified by patient
characteristics and t tests were carried out to compare
Table 1 Co-Morbidities Reported in Patient and in the GPPS
Questionnaires
Patient Questionnaires GPPS Questionnaire
Heart disease Angina or long-term heart problem
Arthritis Arthritis or long-term joint problem
Lung disease Asthma or long-term chest problem
Cancer Cancer in the last 5 years
Diabetes Diabetes
High blood pressure High blood pressure
Kidney or Liver disease Kidney or liver disease
Depression Long-term mental health problem
Nervous system Long-term neurological problem
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differences between patients’ EQ-5D means and popula-
tion EQ-5D means by patient characteristics.
Despite the left skew of the EQ-5D data, we opted to use
the paired t-test for comparisons between the three patient
groups and population for three reasons. First, it enabled
preservation of consistency in our comparisons between all
the comparators. Second, the sample sizes satisfied guide-
lines for using parametric comparisons. And third, the t-test
does not require the assumption of equal dispersion (equal
variance) in the data when comparing between groups.
Results
Comparison of Matching Methods with
Hip Arthroplasty Patients
Of 244 hip arthroplasty patients (80 men with mean age of
66 (range 35–90); 160 women with a mean age of 69 (range
29–90)). 25 were excluded because of missing data: 4
incomplete EQ-5D; 20 missing co-morbidities; one missing
data on SES. Analyses were conducted with three different
matching strategies:
Matched for Age, Sex, SES and Number of
Comorbidities
The median number of matches per patient was 2434 (range
0–8052) though three patients could not be matched. The
difference in EQ-5D scores between patients and the popu-
lation was large (between 0.26 and 0.40) across all cate-
gories of patient characteristics.
Matched for Age, Sex, SES, Number of
Comorbidities and Local Authority
The median number of matches per patient was 241 (range
0–1305); 17 patients could not be matched. The difference in
mean EQ-5D between patients and the population was the
same when matching was restricted to the same local author-
ity and remained highly statistically significant (p<0.001)
(Figure 1). Differences still ranged from 0.21–0.35 for dif-
ferent age, sex and SES categories (not shown).
Matched for Age, Sex, SES and Specific
Comorbidities
The median number of matches per patient was 336 (range
0–9832); seven patients could not be matched. The matched
population mean EQ-5D was 0.64 (SD 0.23) which was
significantly higher than the patients’ mean of 0.22 (SD
0.35); difference 0.42 (CI 0.39–0.44; p<0.001) (Table 2).
Matching for specific comorbidities did not change the extent
of the differences between population and patients' EQ-5D
scores overall compared with matching by number of co-
morbidities (Figure 2). The difference for age and sex sub-
groups ranged from 0.21–0.35 using specific comorbidities
compared with 0.26–0.40 using the number of conditions.
Comparisons of Patients’ and Population
EQ-5D for Three Patient Groups
Of 261 emergency laparotomy patients (121 men with mean
age of 61 (range 18–90); 131 women with a mean age of 62
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Figure 1 Impact of matching by local authority: comparison of difference in mean EQ-5D between hip arthroplasty patients and population reports (by age and sex).
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(range 21–91)). Nine were missing a complete baseline EQ-
5D score, 19 were missing SES and four were missing co-
morbidities. The median number of matches was 250 (range
0–11,421); five patients could not be matched. Of 396 PCI
patients (305 men with mean age of 61 (range 27–92); 85
women with a mean age of 66 (range 44–94)). Six were
missing a complete baseline EQ-5D score, 23 were missing
SES, and one was missing comorbidities. The median number
of matches 139 (range 0–11,541); six could not be matched.
The significant difference between hip arthroplasty
patients’ mean EQ-5D and that of a matched population
already reported (0.42; CI 0.39–0.44) (Table 2) was also
observed for emergency laparotomy patients, although the
size of the difference was smaller (0.13; CI 0.10–0.15,
p<0.001) (Table 3). While the difference for PCI patients was
also statistically significant, the direction of difference was
reversed with the patients reporting better health than the
matched population (−0.09; Cl −0.12 to −0.07, p<0.001)
(Table 4).
When stratified by patient characteristics, the mean
differences of patients’ EQ-5D from that of their matched
populations were significantly different across nearly all
stratified groups for all three patient groups. With the
exception of PCI patients, patients’ reported a lower base-
line EQ-5D than that for the matched population. The only
categories for which there was no significant difference
were for emergency laparotomy patients over 70 years of
age, and with 3+ co-morbidities (Table 3).
Discussion
Main Findings
Modifying the most basic form of matching (using the
whole population adjusted for sex, age, SES and number
of comorbidities) by also taking locality and the specific
comorbid conditions into account made no substantial
difference to the estimated EQ-5D mean score. Given the
larger sample available when using national data, match-
ing using the whole population is the preferred option.
Despite the use of specific comorbidities conferring no
benefit over a simple count from the exploratory matching
with hip patients, the former was chosen for comparing differ-
ences between patients and the population as co-morbidity has
Table 2 Comparison of Mean EQ-5D (95% CI) of Hip Arthroplasty Patients and Population (Matched for Age, Sex, SES, and Specific
Comorbidities)
Patient Characteristic Patients Population Difference in Means (95% CI)
Number Mean EQ-5D (SD) Number Mean EQ-5D (SD)
Overall 240 0.22 (0.35) 178,691 0.64 (0.24) 0.42 (0.39–0.44)
Sex
Male 80 0.29 (0.35) 56,096 0.55 (0.23) 0.26 (0.21–0.31)
Female 160 0.19 (0.34) 122,632 0.48 (0.24) 0.29 (0.25–0.33)
Age
49 or under 18 0.23 (0.36) 20,186 0.56 (0.25) 0.33 (0.21–0.45)
50–69 101 0.23 (0.36) 88,896 0.50 (0.24) 0.26 (0.21–0.31)
70 and above 121 0.21 (0.33) 69,603 0.50 (0.22) 0.29 (0.25–0.32)
SES
1 21 0.28 (0.34) 16,536 0.57 (0.20) 0.29 (0.21–0.37)
2 42 0.20 (0.38) 38,456 0.51 (0.22) 0.31 (0.24–0.38)
3 65 0.25 (0.36) 54,212 0.54 (0.22) 0.29 (0.27–0.34)
4 62 0.27 (0.33) 36,468 0.48 (0.23) 0.21 (0.15–0.26)
5 49 0.13 (0.33) 33,019 0.47 (0.26) 0.34 (0.27–0.41)
missing 1
Comorbidities
0 22 0.24 (0.38) 72,160 0.73 (0.19) 0.49 (0.41–0.57)
1 79 0.29 (0.35) 76,675 0.62 (0.23) 0.33 (0.28–0.38)
2 70 0.23 (0.34) 23,463 0.51 (0.25) 0.28 (0.22–0.34)
3 or more 49 0.11 (0.34) 6393 0.42 (0.26) 0.31 (0.24–0.38)
missing 20
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been shown to influence the health status of respondents in the
GPPS in prior published research.23
Patients’ mean EQ-5D score was significantly different
than that of the general population for all three cohorts.
The difference was greatest for elective hip arthroplasty
patients (0.22 v 0.64), less for emergency laparotomy
(0.56 v 0.72) and least for PCI (0.79 v 0.71) in whom
the direction of difference was reversed with patients
reporting higher baseline EQ-5D than the population.
This corresponds to the clinical context in which hip
arthroplasty patients have a long-standing condition char-
acterised by pain and limited mobility, whereas the other
two cohorts of emergency patients may have enjoyed
reasonable health until an unexpected acute episode led
to their emergency admission. This is particularly true for
the PCI patients, many of whom had no prior symptoms
making it plausible they had better health status than those
in the matched population of respondents to the GPPS.
The only sub-groups in whom their self-reported EQ-5D
did not differ significantly from that of the matched popu-
lation were those emergency laparotomy patients who
were least healthy (aged over 70 years, and with two or
more comorbidities).
Our findings differ from most published studies which
have reported general populations being healthier than
patients.5–7,9–11 This reflects that most of those studies
were limited to trauma patients rather than patients with
long-term illnesses or conditions.5–7,9–14 The one excep-
tion was a study of medical inpatients which reported
similar findings to our study.15 Thus, our findings are
consistent with the suggestions by other authors that the
acute injury population may be healthier, whereas patients
with medical and surgical needs are less healthy compared
to the general population.
These findings confirm that routine PRO data acquired
from population surveys cannot be used as an accurate
alternative to retrospectively reported PROs by medical
and surgical patients during their emergency admission
episode.
Strengths and Limitations
There are three limitations to consider. First, the validity of
the GPPS data. Although it is a large national survey, the
response rate in 2011–2012 was only 38%, albeit similar to
that achieved in other surveys using a similar methodology.17
In addition, co-morbidity data weremissing for 13% and EQ-
5D scores were incomplete for 20%.23 Responders are more
likely to be women, middle-aged and those in affluent areas,
factors that will influence the mean EQ-5D score. However,
given that in this study the data were matched for sex, age
and SES, any response bias will be limited to any other
characteristics such as ethnic group or educational attainment
or indeed health status itself.24 Although it is not possible to
estimate the impact of bias due to these variables, published
Figure 2 Impact of matching by specific comorbid condition: comparison of difference in mean EQ-5D between hip arthroplasty patients and population reports (by age and sex).
Kwong et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Patient Related Outcome Measures 2020:1144
meta-analyses on probability sampled surveys suggest that
response rates are not a strong predictor for response bias.25
Second, comorbidity data in both the retrospective patient
cohorts and the GPPS are based on respondents’ reports. In
both samples, it is possible that respondents might under or
over-report conditions. However, previous studies suggest
that the incidence of comorbidities reported by patients is
similar to that from medical records except for diabetes, high
blood pressure and long-term back problems.23
Finally, the stratified analysis used may not have been
adequate to control for confounding as EQ-5D is age-
dependent; however, cross tabulation of stratified age
(ten-year bands) of EQ-5D scores revealed no significant
associations with sex or SES.
Implications for Policy
These exploratory findings show that use of the GPPS
is not suitable for use in place of a retrospective PRO
in three particular patient groups. Population and
groups of patients remain significantly different even
with specific matching and only in certain sub-
segments of the population were they similar. It
would, therefore, not be appropriate to assess the out-
come of care for those admitted as emergencies by
comparing their PRO scores with that derived from
the general population. In the situation of hip arthro-
plasty and EL patients, given that before their admis-
sion the health status of these patients is, on average,
significantly worse than their matched peers in the
population, it is not reasonable to expect that they
will attain the mean level of health status of the popu-
lation. To assume that may suggest that the care they
receive both during their emergency admission and
subsequently in the community is sub-optimal. The
reverse is true of PCI patients. Thus the use of PROs
in emergency admissions needs to incorporate retro-
spectively collected PROs. The challenge is how this
can be done routinely in a cost-effective way.
Table 3 Comparison of Mean EQ-5D (95% CI) of Emergency Laparotomy Patients and Population (Matched for Age, Sex, SES, Local
Authority and Specific Comorbidities)
Patient Characteristic Patients Population Difference in Means (95% CI)
Number Mean EQ-5D (SD) Number Mean EQ-5D (SD)
Overall 252 0.56 (0.40) 374,519 0.72 (0.22) 0.13 (0.10–0.15)
Sex
Male 121 0.62 (0.35) 152,375 0.66 (0.22) 0.04 (0.001–0.08)
Female 131 0.50 (0.43) 219,555 0.65 (0.23) 0.15 (0.11–0.18)
Age
49 or under 62 0.48 (0.46) 186,329 0.72 (0.20) 0.24 (0.19–0.29)
50–69 94 0.52 (0.39) 120,612 0.63 (0.24) 0.11 (0.06–0.16)
70 and above 96 0.66 (0.33) 64,989 0.64 (0.23) −0.02 (−0.1–0.06) p=0.62*
SES
1 37 0.57 (0.39) 86,250 0.79 (0.21) 0.22 (0.15–0.28)
2 45 0.61 (0.43) 51,128 0.73 (0.21) 0.10 (0.04–0.15)
3 47 0.66 (0.31) 93,699 0.75 (0.21) 0.09 (0.03–0.14)
4 51 0.53 (0.37) 60,014 0.66 (0.25) 0.13 (0.06–0.19)
5 53 0.45 (0.42) 77,103 0.58 (0.27) 0.13 (0.06–0.20)
missing 19
Comorbidities
0 56 0.66 (0.39) 299,449 0.81 (0.16) 0.15 (0.11–0.19)
1 80 0.60 (0.39) 59,163 0.74 (0.23) 0.14 (0.09–0.19)
2 50 0.53 (0.39) 8988 0.60 (0.26) 0.07 (0.002–0.14)
3 or more 62 0.46 (0.39) 4330 0.41 (0.26) −0.05 (−0.1–0.02) p=0.17*
missing 4
Note: *No significant difference between patients and population.
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Ethical Approval and Informed
Consent
All procedures performed in studies involving human partici-
pants were in accordance with the ethical standards of the
institutional and national research committee (NHS Health
Research Authority) and with the 1964 Helsinki declaration
and its later amendments or comparable ethical standards.
NHS ethical approval obtained from Health Research
Authority North East - Newcastle & North Tyneside 2
Research Ethics Committee (REC Ref: 16/NE/0081) and
South East Coast - Brighton & Sussex Research Ethics
Committee (REC reference: 16/LO/2053). Written Informed
consent was obtained from all individual participants included
in the study. Only anonymised large GPPS population means
data were used.
Acknowledgments
We thank the patients and staff of the 20 hospitals that
participated in the three patient cohort studies, the Site and
Study leads.
Site and study leads collaborators: Mike Grocott, David
Murray, David Saunders, Jose Lourtie, Steffen Petersen, Fares
Haddad, Mahbub Alam, Rej Bumbra, Joyti Saksena, Jamila
Kassam, Ursula Knight, Mark Vertue, Joanne Riches, Julie
Saunders, Mervyn Andiapen, Jonathan Breeze, Amy Hoare,
Alison Pottle, Paula Rogers, Claire Prendergast, Michael
Lewis, Gill Pout, Patricia Dickens, James Kirkby-bott,
Pauline Bartlett, Guy Titley, Emma Willett, Nina Barratt,
Tanuja Shah, Kathleen Holding, Lianne Hufton, Veeranna
Shatkar, Ruwan Weerakkody, Caron Baldwin, Sarah Hare,
Annette Woods, Ewen Griffiths, Arlo Whitehouse, Jugdeep
Dhesi, Jane Okello, Philip Braude, Karen Wilson, Kirsty
Gibson, Abdul Quddus, Davina Ross-Anderson, Katherine
MacGloin, Hasan Mukhtar, Kathryn Simpson, Kayleigh
Gilbert, Mark Vertue, Joanne Riches, Julie Saunders,
Mervyn Andiapen, Jonathan Breeze, Amy Hoare, Alison
Pottle, Paula Rogers, Claire Prendergast, Michael Lewis, Gill
Pout, Patricia Dickens, James Kirkby-bott, Pauline Bartlett,
Guy Titley, Emma Willett, Nina Barratt, Tanuja Shah,
Kathleen Holding, Lianne Hufton.
Table 4 Comparison of Mean EQ-5D (95% CI) of PCI Patients and Population (Matched for Age, Sex, SES, Local Authority and
Specific Comorbidities)
Patient Characteristic Patients Population Difference in Means (95% CI)
Number Mean EQ-5D (SD) Number Mean EQ-5D (SD)
Overall 390 0.79 (0.28) 411,388 0.71 (0.23) −0.09 (−0.12–0.07)
Sex
Male 305 0.81 (0.28) 339,012 0.67(0.22) −0.14 (−0.16–0.12)
Female 85 0.74 (0.29) 72,376 0.59 (0.26) −0.15 (−0.21–0.09)
Age
49 or under 60 0.76 (0.36) 90,926 0.64 (0.21) −0.12 (−0.17–0.07)
50–69 219 0.80 (0.28) 270,628 0.67 (0.23) −0.13 (−0.16–0.10)
70 and above 111 0.80 (0.23) 49,834 0.68 (0.24) −0.13 (−0.17–0.09)
SES
1 69 0.85 (0.20) 90,276 0.72 (0.20) −0.13 (−0.18–0.08)
2 60 0.83 (0.22) 96,405 0.75 (0.23) −0.08 (−0.14–0.02)
3 90 0.79 (0.23) 81,817 0.69(0.23) −0.10 (−0.15–0.05)
4 93 0.73 (0.37) 87,157 0.65(0.24) −0.08 (−0.13–0.03)
5 55 0.77 (0.34) 47,536 0.61 (0.27) −0.16 (−0.23–0.09)
missing 23
Comorbidities
0 57 0.90 (0.16) 311,228 0.83 (0.17) −0.07(−0.11–0.03)
1 109 0.88 (0.18) 75,761 0.75 (0.20) −0.013(−0.17–0.09)
2 94 0.81 (0.26) 17,722 0.71(0.24) −0.10 (−0.15–0.05)
3 or more 129 0.66 (0.35) 6677 0.45 (0.26) −0.21 (−0.28–0.14)
missing 1
Kwong et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Patient Related Outcome Measures 2020:1146
Author Contributions
All authors contributed to data analysis, drafting or revising
the article, gave final approval of the version to be published,
and agree to be accountable for all aspects of the work.
Funding
EK is funded by Economic & Social Research Council
doctoral fellowship. Grant Reference: ES/J500021/1.
The research was supported by the National Institute for
Health Research (NIHR) Collaboration for Leadership in
Applied Health Research and Care North Thames at Barts
Health NHS Trust. The views expressed are those of the
authors and not necessarily those of the NHS, the NIHR or
the Department of Health.
Disclosure
The authors declare no conflicts of interest in this work.
References
1. Black N. Patient reported outcome measures could help transform
healthcare. BMJ. 2013;346:19–21. doi:10.1136/bmj.f167
2. Greenhalgh J, Dalkin S, Gooding K, et al. Functionality and feedback:
a realist synthesis of the collation, interpretation and utilisation of
patient-reported outcome measures data to improve patient care.
Health Serv Deliv Res. 2017;5(2):1–280.
3. Kwong E, Black N. Retrospectively collected patient reported outcomes
show strong association and agreementwith their contemporaneous reports.
J Clin Epidemiol. 2017;81:22–32. doi:10.1016/j.jclinepi.2016.09.002
4. Kwong E, Neuburger J, Black N. Agreement between retrospectively
and contemporaneously collected patient-reported outcome measures
(PROMs) in hip and knee replacement patients. Qual Life Res.
2018;27:1845–1854. doi:10.1007/s11136-018-1823-6
5. Ameratunga SN, Norton RN, Connor JL, et al. A population-based
cohort study of longer-term changes in health of car drivers involved
in serious crashes. Ann Emerg Med. 2006;48(6):729–736. doi:10.1016/
j.annemergmed.2006.07.001
6. Gabbe BJ, Cameron PA, Graves SE, Williamson OD, Edwards ER.
Preinjury status: are orthopaedic trauma patients different than the general
population? J Orthop Trauma. 2007;21(4):223–228. doi:10.1097/
BOT.0b013e31803eb13c
7. Watson WL, Ozanne-Smith J, Richardson J. Retrospective baseline
measurement of self-reported health status and health-related quality
of life versus population norms in the evaluation of post-injury losses.
Inj Prev. 2007;13(1):45–50. doi:10.1136/ip.2005.010157
8. Lange RT, Iverson GL, Rose A. Post-concussion symptom reporting and
the “good-old-days” bias followingmild traumatic brain injury. Arch Clin
Neuropsychol. 2010;25(5):442–450. doi:10.1093/arclin/acq031
9. Lyons RA, Kendrick D, Towner EM, et al. Measuring the population
burden of injuries–implications for global and national estimates:
a multi-centre prospective UK longitudinal study. PLoS Med. 2011;8
(12):e1001140. doi:10.1371/journal.pmed.1001140
10. Tøien K, Bredal IS, Skogstad L, Myhren H, Ekeberg O. Health
related quality of life in trauma patients. Data from a one-year follow
up study compared with the general population. Scand J Trauma
Resusc Emerg Med. 2011;19(1):22. doi:10.1186/1757-7241-19-22
11. Wilson R, Derrett S, Hansen P, Langley J. Retrospective evaluation versus
population norms for the measurement of baseline health status. Health
Qual Life Outcomes. 2012;10(1):68. doi:10.1186/1477-7525-10-68
12. Mock C, MacKenzie E, Jurkovich G, et al. Determinants of disability
after lower extremity fracture. J Trauma. 2000;49(6):1002–1011.
doi:10.1097/00005373-200012000-00005
13. Michaels AJ, Madey SM, Krieg JC, Long WB. Traditional injury
scoring underestimates the relative consequences of orthopedic
injury. J Trauma. 2001;50(3):389–95; discussion 396. doi:10.1097/
00005373-200103000-00001
14. Tidermark J, Zethraeus N, Svensson O, Törnkvist H, Ponzer S.
Femoral neck fractures in the elderly: functional outcome and quality
of life according to EuroQol. Qual Life Res. 2002;11(5):473–481.
doi:10.1023/A:1015632114068
15. Gifford J, Husain N, Dinglas V, Colantuoni E, Needham DM.
Baseline quality of life before intensive care: a comparison of patient
versus proxy responses. Crit Care Med. 2010;38(3):855–860.
doi:10.1097/CCM.0b013e3181cd10c7.Baseline
16. NHS England. GP patient survey. 2017. Available from: https://www.
england.nhs.uk/statistics/2017/07/06/gp-patient-survey-2017/.
17. Campbell J, Smith P, Nissen S, Bower P, Elliott M, Roland M.
The GP patient survey for use in primary care in the National
Health Service in the UK – development and psychometric char-
acteristics. BMC Fam Pract. 2009;10(1):57. doi:10.1186/1471-
2296-10-57
18. NHS England. GPPS surveys and reports; 2017. Available from: www.
gpatient.co.uk/download/Questionnaires/. Accessed January 16, 2020
19. EuroQol Group. EuroQol – a new facility for the measurement of
health-related quality of life. Health Policy (New York).
1990;16:199–208. doi:10.1016/0168-8510(90)90421-9
20. Dolan P, Roberts J. Modelling valuations for Eq-5d health states: an
alternative model using differences in valuations. Med Care.
2002;40:442–446. doi:10.1097/00005650-200205000-00009
21. Kwong E, Black N. Feasibility of collecting retrospective patient reported
outcome measures (PROMs) in emergency hospital admissions. J Patient
Rep Outcomes. 2018;2(1):54. doi:10.1186/s41687-018-0077-y
22. Department for Communities and Local Government. English Indices
of Deprivation. Crown Copyright; 2015.
23. Mujica-Mota RE, Roberts M, Abel G, et al. Common patterns of
morbidity and multi-morbidity and their impact on health-related
quality of life: evidence from a national survey. Qual Life Res.
2015;24(4):909–918. doi:10.1007/s11136-014-0820-7
24. Burt J, Lloyd C, Campbell J, Roland M, Abel G. Variations in GP–
patient communication by ethnicity, age, and gender: evidence from
a national primary care patient survey. Br J Gen Pract. 2016;66(642):
e47–e52. doi:10.3399/bjgp15X687637
25. Groves RM, Peytcheva E. The impact of nonresponse rates on non-
response bias: a meta-analysis. Public Opin Q. 2008;72(2):167–189.
doi:10.1093/poq/nfn011
Dovepress Kwong et al
Patient Related Outcome Measures 2020:11 submit your manuscript | www.dovepress.com
DovePress
47
Patient Related Outcome Measures Dovepress
Publish your work in this journal
Patient Related Outcome Measures is an international, peer-reviewed,
open access journal focusing on treatment outcomes specifically
relevant to patients. All aspects of patient care are addressed within
the journal and practitioners from all disciplines are invited to submit
their work as well as healthcare researchers and patient support groups.
The manuscript management system is completely online and
includes a very quick and fair peer-review system. Visit http://www.
dovepress.com/testimonials.php to read real quotes from published
authors.
Submit your manuscript here: http://www.dovepress.com/patient-related-outcome-measures-journal
Kwong et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Patient Related Outcome Measures 2020:1148
